89 related articles for article (PubMed ID: 27451036)
1. Zirconyl acetaminophen phosphate: A nanoscaled analgetic with very high drug load.
Heck JG; Feldmann C
J Colloid Interface Sci; 2016 Nov; 481():69-74. PubMed ID: 27451036
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional phosphate-based inorganic-organic hybrid nanoparticles.
Heck JG; Napp J; Simonato S; Möllmer J; Lange M; Reichardt HM; Staudt R; Alves F; Feldmann C
J Am Chem Soc; 2015 Jun; 137(23):7329-36. PubMed ID: 26018463
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of composite poly(d,l-lactide)/montmorillonite nanoparticles for controlled delivery of acetaminophen by solvent-displacement method using glass capillary microfluidics.
Othman R; Vladisavljević GT; Thomas NL; Nagy ZK
Colloids Surf B Biointerfaces; 2016 May; 141():187-195. PubMed ID: 26852102
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent Sulfonate-Based Inorganic-Organic Hybrid Nanoparticles for Staining and Imaging.
Poß M; Zittel E; Meschkov A; Schepers U; Feldmann C
Bioconjug Chem; 2018 Aug; 29(8):2818-2828. PubMed ID: 30004681
[TBL] [Abstract][Full Text] [Related]
5. Comparative release studies on suppositories using the basket, paddle, dialysis tubing and flow-through cell methods I. Acetaminophen in a lipophilic base suppository.
Hori S; Kawada T; Kogure S; Yabu S; Mori K; Akimoto M
Pharm Dev Technol; 2017 Feb; 22(1):130-135. PubMed ID: 27574857
[TBL] [Abstract][Full Text] [Related]
6. Low temperature synthesis of monodisperse nanoscaled ZrO2 with a large specific surface area.
Zink N; Emmerling F; Häger T; Panthöfer M; Tahir MN; Kolb U; Tremel W
Dalton Trans; 2013 Jan; 42(2):432-40. PubMed ID: 23108106
[TBL] [Abstract][Full Text] [Related]
7. Solventless dry powder coating for sustained drug release using mechanochemical treatment based on the tri-component system of acetaminophen, carnauba wax and glidant.
Hoashi Y; Tozuka Y; Takeuchi H
Drug Dev Ind Pharm; 2013 Feb; 39(2):259-65. PubMed ID: 22494100
[TBL] [Abstract][Full Text] [Related]
8. Development of drug adsorbates onto soluble inorganic silicate glass surface: example with acetaminophen.
Hristova Y; Djambaski P; Samuneva B; Rangelova N; Bogdanova S
J Mater Sci Mater Med; 2008 Feb; 19(2):805-11. PubMed ID: 17665109
[TBL] [Abstract][Full Text] [Related]
9. Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI.
Cheng Z; Dai Y; Kang X; Li C; Huang S; Lian H; Hou Z; Ma P; Lin J
Biomaterials; 2014 Aug; 35(24):6359-68. PubMed ID: 24816364
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological screening of glycine amino acid prodrug of acetaminophen.
Parashar A
Indian J Pharmacol; 2015; 47(2):202-5. PubMed ID: 25878383
[TBL] [Abstract][Full Text] [Related]
11. Release mechanisms of acetaminophen from polyethylene oxide/polyethylene glycol matrix tablets utilizing magnetic resonance imaging.
Tajiri T; Morita S; Sakamoto R; Suzuki M; Yamanashi S; Ozaki Y; Kitamura S
Int J Pharm; 2010 Aug; 395(1-2):147-53. PubMed ID: 20580795
[TBL] [Abstract][Full Text] [Related]
12. A Quantitative Analysis of Drug Loading Efficiency and Real-Time Drug Release in ZrO₂ Nanoparticles with Energy Spectrum Computed Tomography.
Ji W; Qi X; Li H; Zhang Y; Sun Y; Wang J; Xu K; Liu Y
J Biomed Nanotechnol; 2021 Apr; 17(4):703-709. PubMed ID: 35057895
[TBL] [Abstract][Full Text] [Related]
13. Formulation and characterization of acetaminophen nanoparticles in orally disintegrating films.
Al-Nemrawi NK; Dave RH
Drug Deliv; 2016; 23(2):540-9. PubMed ID: 25013958
[TBL] [Abstract][Full Text] [Related]
14. Light-activated drug release from prodrug nanoassemblies by structure destruction.
Li Y; Wang S; Huang Y; Chen Y; Wu W; Liu Y; Zhang J; Feng Y; Jiang X; Gou M
Chem Commun (Camb); 2019 Oct; 55(87):13128-13131. PubMed ID: 31616871
[TBL] [Abstract][Full Text] [Related]
15. Influence of pH and phospholipid species on release of acetaminophen from tablets containing phospholipids.
Fujii M; Moriyama J; Hamazumi N; Matsumoto M
Chem Pharm Bull (Tokyo); 1998 Feb; 46(2):304-8. PubMed ID: 9501466
[TBL] [Abstract][Full Text] [Related]
16. The effect of molecular structure on the anticancer drug release rate from prodrug nanoparticles.
Ikuta Y; Koseki Y; Onodera T; Oikawa H; Kasai H
Chem Commun (Camb); 2015 Aug; 51(64):12835-8. PubMed ID: 26165183
[TBL] [Abstract][Full Text] [Related]
17. Highly selective organ distribution and cellular uptake of inorganic-organic hybrid nanoparticles customized for the targeted delivery of glucocorticoids.
Kaiser TK; Khorenko M; Moussavi A; Engelke M; Boretius S; Feldmann C; Reichardt HM
J Control Release; 2020 Mar; 319():360-370. PubMed ID: 31923534
[TBL] [Abstract][Full Text] [Related]
18. Fabrication, characterization, and evaluation in drug release properties of magnetoactive poly(ethylene oxide)-poly(L-lactide) electrospun membranes.
Savva I; Odysseos AD; Evaggelou L; Marinica O; Vasile E; Vekas L; Sarigiannis Y; Krasia-Christoforou T
Biomacromolecules; 2013 Dec; 14(12):4436-46. PubMed ID: 24261831
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid.
Dalpiaz A; Contado C; Mari L; Perrone D; Pavan B; Paganetto G; Hanuskovà M; Vighi E; Leo E
Drug Deliv; 2014 May; 21(3):221-32. PubMed ID: 24134683
[TBL] [Abstract][Full Text] [Related]
20. Critical size of crystalline ZrO(2) nanoparticles synthesized in near- and supercritical water and supercritical isopropyl alcohol.
Becker J; Hald P; Bremholm M; Pedersen JS; Chevallier J; Iversen SB; Iversen BB
ACS Nano; 2008 May; 2(5):1058-68. PubMed ID: 19206504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
